KYMR
Kymera Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$118.18
+0.76%Leverage
- Debt / equity
- 0.05x
- Net debt / equity
- -0.03x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.28x
- Net debt / EBITDA
- 0.14x
Liquidity & coverage
- Current ratio
- 9.83x
- Quick ratio
- 9.91x
- Cash ratio
- 9.21x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $662.3M
Cash & dividend
- FCF / debt
- -2.89x
- Cash flow / debt
- -2.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026